Document is current
Any future updates will be listed below
-
Authors
Marcucci, Gemma
Brandi, Maria Luisa
-
Funding
Funding for this research was provided by:
Università degli Studi di Firenze
- License Information
-
More Information
Article History
Received: 31 July 2024
Accepted: 26 December 2024
First Online: 22 January 2025
Declarations
:
: GM: Support for attending meetings and/or travel: Amgen; MLB: Honoraria: Amgen, Ascendis, Bruno, Farmaceutici, Calcilytix, Kyowa Kirin, UCB; Grants and/or speaker, support for attending meetings and/or travel: Abiogen, Alexion, Amgen, Amolyt, Amorphical, Bruno Farmaceutici, CoGeDi, Echolight, Eli Lilly, Enterabio, Gedeon Richter, Italfarmaco, Kyowa Kirin, Menarini, Monte Rosa Therapeutics, SPA, Takeda, Theramex, UCB; Consultant: Aboca, Alexion, Amolyt, Bruno Farmaceutici, Calcilytix, Echolight, Kyowa Kirin, Personal Genomics, Smoke-Free World Foundation.
: Not applicable.
